IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,601,196 | +61626.9% | 39,025 | -46.2% | 0.02% | -52.5% |
| Q1 2023 | $2,594 | +88.8% | 72,577 | +99.6% | 0.04% | +48.1% |
| Q4 2022 | $1,374 | -99.9% | 36,365 | +72.3% | 0.03% | +35.0% |
| Q3 2022 | $934,000 | -66.0% | 21,109 | -71.5% | 0.02% | -72.2% |
| Q2 2022 | $2,747,000 | +151.1% | 74,192 | +151.3% | 0.07% | +176.9% |
| Q1 2022 | $1,094,000 | -79.8% | 29,525 | -83.4% | 0.03% | -71.4% |
| Q4 2021 | $5,428,000 | -19.7% | 178,386 | -11.5% | 0.09% | -17.3% |
| Q3 2021 | $6,762,000 | +69.7% | 201,613 | +101.8% | 0.11% | +46.7% |
| Q2 2021 | $3,984,000 | +88.1% | 99,886 | +123.7% | 0.08% | -18.5% |
| Q3 2020 | $2,118,000 | +287.9% | 44,644 | +286.7% | 0.09% | +87.8% |
| Q1 2020 | $546,000 | -41.7% | 11,546 | -20.8% | 0.05% | +81.5% |
| Q2 2019 | $937,000 | +354.9% | 14,576 | +475.2% | 0.03% | +200.0% |
| Q1 2019 | $206,000 | -71.0% | 2,534 | -80.7% | 0.01% | -35.7% |
| Q4 2018 | $710,000 | +234.9% | 13,135 | +44.3% | 0.01% | +250.0% |
| Q2 2016 | $212,000 | – | 9,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |